Rumor Mill
Celgene Surges as Bristol-Myers Squibb Blockbuster Deal Begins Year With a Bang
Big pharma could be primed for an M&A Boom after Bristol-Myers Squibb's blockbuster deal for Celgene.
Chart of the Day, Part 1: Tilray, AB Deal Pales in Comparison to Cronos
The buy-in from other companies into the space has been far larger.
Huawei and Nissan Arrests Hitting Asian Confidence Hard
Asian markets have been spooked by the fall of these mighty executives.
There's Trouble at the Top of Walmart's Largest Ever Acquisition
Any way you slice it, rapid reorganization of Flipkart only months after its purchase does not reflect well on Walmart.
Jim Cramer ExxonMobil's Bid for InterOil Is 'Anything but Conservative'
Jim Cramer says ExxonMobil's $2.2 billion bid for InterOil isn't that much money for Exxon, but is 'anything but conservative.'